These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11281558)

  • 1. Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha.
    Kanno N; Glaser S; Chowdhury U; Phinizy JL; Baiocchi L; Francis H; LeSage G; Alpini G
    J Hepatol; 2001 Feb; 34(2):284-91. PubMed ID: 11281558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.
    Alpini G; Kanno N; Phinizy JL; Glaser S; Francis H; Taffetani S; LeSage G
    Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G973-82. PubMed ID: 14701718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms.
    Glaser S; Benedetti A; Marucci L; Alvaro D; Baiocchi L; Kanno N; Caligiuri A; Phinizy JL; Chowdury U; Papa E; LeSage G; Alpini G
    Hepatology; 2000 Jul; 32(1):17-25. PubMed ID: 10869284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway.
    Fava G; Marucci L; Glaser S; Francis H; De Morrow S; Benedetti A; Alvaro D; Venter J; Meininger C; Patel T; Taffetani S; Marzioni M; Summers R; Reichenbach R; Alpini G
    Cancer Res; 2005 Dec; 65(24):11437-46. PubMed ID: 16357152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein kinase Calpha couples cell volume to membrane Cl- permeability in HTC hepatoma and Mz-ChA-1 cholangiocarcinoma cells.
    Roman RM; Bodily KO; Wang Y; Raymond JR; Fitz JG
    Hepatology; 1998 Oct; 28(4):1073-80. PubMed ID: 9755245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
    Francis H; Onori P; Gaudio E; Franchitto A; DeMorrow S; Venter J; Kopriva S; Carpino G; Mancinelli R; White M; Meng F; Vetuschi A; Sferra R; Alpini G
    Mol Cancer Res; 2009 Oct; 7(10):1704-13. PubMed ID: 19825989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms for the growth factor action of gastrin.
    Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T
    Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
    Ohlsson B; Fredäng N; Axelson J
    Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas.
    Rooman I; Lardon J; Flamez D; Schuit F; Bouwens L
    Gastroenterology; 2001 Oct; 121(4):940-9. PubMed ID: 11606507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.
    Alvaro D; Barbaro B; Franchitto A; Onori P; Glaser SS; Alpini G; Francis H; Marucci L; Sterpetti P; Ginanni-Corradini S; Onetti Muda A; Dostal DE; De Santis A; Attili AF; Benedetti A; Gaudio E
    Am J Pathol; 2006 Sep; 169(3):877-88. PubMed ID: 16936263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of human cholangiocarcinoma cells induced by ESC-3 from Crocodylus siamensis bile.
    Song W; Shen DY; Kang JH; Li SS; Zhan HW; Shi Y; Xiong YX; Liang G; Chen QX
    World J Gastroenterol; 2012 Feb; 18(7):704-11. PubMed ID: 22363144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma.
    Smith JP; Shih AH; Wotring MG; McLaughlin PJ; Zagon IS
    Int J Oncol; 1998 Feb; 12(2):411-9. PubMed ID: 9458369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity.
    Lesage GD; Marucci L; Alvaro D; Glaser SS; Benedetti A; Marzioni M; Patel T; Francis H; Phinizy JL; Alpini G
    Hepatology; 2002 Sep; 36(3):641-51. PubMed ID: 12198656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gastrin on human astrocytic tumor cell proliferation.
    Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
    J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Ding XQ; Chen D; Håkanson R
    Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways.
    Tu S; Chi AL; Lim S; Cui G; Dubeykovskaya Z; Ai W; Fleming JV; Takaishi S; Wang TC
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1726-37. PubMed ID: 17332476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y; Shulkes A
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.
    Kanno N; Lesage G; Phinizy JL; Glaser S; Francis H; Alpini G
    Hepatology; 2002 Jun; 35(6):1329-40. PubMed ID: 12029618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK2 (CCK(B)/gastrin) receptor mediates rapid protein kinase D (PKD) activation through a protein kinase C-dependent pathway.
    Chiu T; Rozengurt E
    FEBS Lett; 2001 Jan; 489(1):101-6. PubMed ID: 11231022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro.
    Piontek MK; Hengels KJ
    Anticancer Res; 1993; 13(3):715-20. PubMed ID: 8317902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.